Ubiquinone and ubiquinol are two forms of coenzyme Q10 (CoQ10), with ubiquinone being the oxidized form and ubiquinol being the reduced form
Semaglutide (Wegovy) At the current maximum approved dose of 2.4 mg, estimated 68-week weight loss is around 17.0%, based on data from the 72 week STEP-UP trial
Human trials demonstrate significant boosts in desire and satisfaction, with women reporting more sexually satisfying events and reduced distress.[1][2] Phase 3 data from over 1,200 premenopausal women showed efficacy and safety, with common side effects like nausea being mild and transient
By Kristin Jensen July 15, 2026 Brain drug revival Biogen data highlight promise, questions surrounding tau-targeting Alzheimers drugs The study provides the clearest evidence yet that medicines like BIIB080 might improve cognition, but leaves unclear why higher doses didnt perform better
A meta-analysis of brain morphometric aberrations in adolescents who experienced childhood trauma